Novartis terminates plant contract with Chinese CDMO Porton, threatens $64M in legal claims

18th May 2026 Uncategorised 0

A Novartis cross-border partnership is turning into a standoff. The Swiss pharma has unilaterally terminated a plant leasing contract with Chinese CDMO Porton Pharma Solutions after a regulatory hiccup.

More: Novartis terminates plant contract with Chinese CDMO Porton, threatens M in legal claims
Source: fierce